Key result
Cardiac rehab is linked to improved physical metrics except in HFrEF and HFmrEF patients ≥80.
Why the study?
The universal application of cardiac rehabilitation often overlooks heterogeneity within the geriatric population, leaving disparities in response across demographics, heart failure subtypes, and angina classifications unclear.
Does a 12-week cardiac rehabilitation program improve physical metrics in older geriatric patients following cardiac events or procedures?
Observational (n=438)
Does a 12-week cardiac rehabilitation program improve physical metrics in older geriatric patients following cardiac events or procedures?
A 12-week cardiac rehabilitation program significantly improves physical metrics in older patients, though benefits vary by heart failure subtype, highlighting the need for personalized programs.
May not extend to octogenarians with HFrEF/HFmrEF; leaves open whether tailored programs benefit this subgroup.
Background While cardiac rehabilitation (CR) is recognized for enhancing physical fitness, psychological well-being, and overall quality of life in cardiac patients, its universal application often overlooks the heterogeneity within the geriatric population. This study delves into the effectiveness of CR among older geriatric patients, aiming to uncover the disparities in response across various demographics, heart failure subtypes, and angina classifications, thereby underscoring the imperative for personalized CR programs. Methods We retrospectively analyzed 438 CR participants from December 2020 to December 2023, stratifying them by age (median: 65.14 years, IQR: 57.23-72.64), sex (23.74% female), heart failure subtype, and CCS angina class to identify distinct response patterns to CR. The analysis included a comprehensive assessment of physical metrics pre- and post-12-week CR program following cardiac surgeries, transcatheter procedures, coronary events, and/or interventions. We employed the Wilcoxon Rank Sum test for statistical analysis, focusing on identifying non-responders and quantifying effect sizes (r) to determine the magnitude of change across various physical metrics. Results Notable improvements were observed in metabolic equivalents (METs) (+1.82), oxygen uptake (VO2 peak) (+6.36 mL/kg/min), Duke Activity Status Index (DASI) score (+14.79), moderate to vigorous physical activity (MVPA) (+131.28 minutes/week), sitting time (-1.21 hours/day), total activity (+145.65 minutes/week) and sit-to-stand repetitions (+2.65). The greatest effect sizes were observed in DASI score (r=0.750) and sit-to-stand (r=SIS) repetitions (r=0.610), consistent across demographics, heart failure, and CCS categories. Other metrics noted variable changes, with handgrip strength showing no consistent trend. Sensitivity analyses revealed that older geriatric patients (≥ 80 years) with HFpEF experienced significant improvements in DASI score (r=0.638), MVPA (r=0.636), and SIS (r=0.504), while those with HFrEF and HFmrEF showed no significant improvements in any physical metrics. CCS angina classification, common comorbidities, and initial referral events did not significantly influence outcomes. Conclusion This study reaffirms the efficacy of CR but crucially identifies the gaps in its universal application, particularly among older geriatric patients with diverse heart failure subtypes. Our analysis advocates for developing personalized CR programs tailored to patients' individual profiles to enhance effectiveness of rehabilitation. By addressing these specific needs, we can ensure more inclusive and optimized patient care, ultimately supporting the expansion of CR indications to foster a more holistic approach to cardiac health in the geriatric population.
No takes yet. Share an insight, caveat, or question.
Arif et al. (2024) conducted an observational in Cardiac patients (n=438). Cardiac rehabilitation was evaluated on Change in physical metrics (METs, VO2 peak, DASI score, MVPA, sitting time, total activity, sit-to-stand repetitions). A 12-week cardiac rehabilitation program improved physical metrics like DASI score (r=0.750), but older patients (≥80 years) with HFrEF and HFmrEF showed no significant improvements.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: